Ayr Wellness Inc.
DB:3KJB Stock Report
Ayr Wellness Dividends and Buybacks
Dividend criteria checks 0/6 Ayr Wellness does not have a record of paying a dividend.
Key information Total Shareholder Yield 0.3% Future Dividend Yield n/a Dividend Growth n/a Next dividend pay date n/a Ex dividend date n/a Dividend per share n/a Payout ratio n/a
Recent dividend and buyback updates
Show all updates Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter 2024
New minor risk - Market cap size Nov 12
Ayr Wellness Inc. to Report Q3, 2024 Results on Nov 13, 2024 Oct 18
New major risk - Shareholder dilution Oct 06 AYR Wellness Inc. Announces Chief Executive Officer Changes
New major risk - Shareholder dilution Aug 11
Second quarter 2024 earnings released: US$0.34 loss per share (vs US$0.42 loss in 2Q 2023) Aug 08 Ayr Wellness Inc. Provides Revenue Guidance for the Third Quarter of 2024
AYR Wellness Inc. Announces Executive Changes Aug 01
Ayr Wellness Inc. to Report Q2, 2024 Results on Aug 02, 2024 Jul 04
First quarter 2024 earnings released: US$1.08 loss per share (vs US$0.13 loss in 1Q 2023) May 16
Ayr Wellness Inc. Provides Earnings Guidance for the Second Quarter of 2024 May 16
Ayr Wellness Inc. to Report Q1, 2024 Results on May 15, 2024 Apr 12
Forecast to breakeven in 2025 Apr 09
Ayr Wellness Inc. Launches Kynd Premium Edibles in Florida and Nevada Mar 27
Less than half of directors are independent Mar 26
Ayr Wellness Inc., Annual General Meeting, May 17, 2024 Mar 19
Full year 2023 earnings released: US$1.16 loss per share (vs US$3.58 loss in FY 2022) Mar 13
Ayr Wellness Inc. Provides Earnings Guidance for the First Quarter of 2024 Mar 13 Ayr Wellness Inc. announced that it expects to receive $48.857663 million in funding Feb 23
New major risk - Shareholder dilution Feb 09
Ayr Wellness Inc. to Report Q4, 2023 Results on Mar 13, 2024 Feb 09
AYR Wellness Inc. Announces Jared Cohen to Join the Board of Directors Feb 08
Third quarter 2023 earnings released: US$0.24 loss per share (vs US$0.52 loss in 3Q 2022) Nov 18
Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter of 2023 Nov 17
Ayr Wellness Inc. to Report Q3, 2023 Results on Nov 16, 2023 Nov 02
New minor risk - Market cap size Oct 29
Now 28% undervalued Sep 26
Second quarter 2023 earnings released Aug 18
Ayr Wellness Inc. Provides Earnings Guidance for the Second Half of 2023 and for the Year 2024 Aug 18
Ayr Wellness Inc. Appoints Michael Warren to Board of Directors Aug 05
Now 21% undervalued after recent price drop May 22
Forecast to breakeven in 2025 May 19
First quarter 2023 earnings released: US$0.13 loss per share (vs US$0.11 loss in 1Q 2022) May 17
Full year 2022 earnings released: US$3.58 loss per share (vs US$0.30 loss in FY 2021) Mar 10 Ayr Wellness Inc. Announces Chief Executive Officer Changes
AZ Goat, LLC entered into a definitive agreement to acquire Blue Camo, LLC from Ayr Wellness Inc. (CNSX:AYR.A) for $20 million. Feb 10
Forecast to breakeven in 2024 Feb 07
Ayr Wellness Inc. Provides Earnings Guidance for the Fourth Quarter of 2022 Nov 11
Ayr Wellness Inc. Appoints David Goubert as President, Effective from November 1, 2022 Oct 13 Ayr Wellness Inc. Brings Concentrates Brand Haze to Florida
Ayr Wellness Inc. to Report Q3, 2022 Results on Nov 10, 2022 Oct 01
Ayr Wellness Inc. Announces the Launch of Lost in Translation Across Four Additional States Sep 23
Independent Director recently bought €60k worth of stock Aug 27
Second quarter 2022 earnings released: US$0.56 loss per share (vs US$0.36 loss in 2Q 2021) Aug 19
Ayr Wellness Inc. Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2022 Aug 19
Ayr Wellness Receives Key Massachusetts Regulatory Approval for Adult-Use Sales in Somerville, Subject to Municipal Approval Aug 13
Ayr Wellness Inc. Receives Key Massachusetts Regulatory Approval for Adult-Use Sales in Somerville, Subject to Municipal Approval; Ayr Announces Approval for Phase 1 of Milford Cultivation Expansion Aug 12
Ayr Wellness Inc. to Report Q2, 2022 Results on Aug 18, 2022 Jul 21
Independent Director recently bought €92k worth of stock Jun 16
Ayr Wellness Inc. to Begin Adult-Use Sales in Its Three New Jersey Dispensaries Jun 14
Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in Watertown Jun 12
Forecast breakeven date pushed back to 2024 Jun 11
Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in Watertown Jun 11
Ayr Wellness Inc. Receives Approval to Begin New Jersey Adult-Use Retail Sales May 28
First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.38 loss in 1Q 2021) May 27 Ayr Wellness Inc. (CNSX:AYR.A) completed the acquisition of Herbal Remedies Dispensaries, LLC.
Ayr Wellness Receives Approval from New Jersey Cannabis Regulatory Commission to Begin New Jersey Adult-Use Retail Sales May 25
Ayr Wellness Inc Receives Final License to Sell Adult-Use Cannabis in the Heart of Boston’s Back Bay, the Company’s First Adult-Use Dispensary in Greater Boston May 13 Ayr Wellness Inc. to Report Q1, 2022 Results on May 26, 2022 May 10
Ayr Wellness Inc., Annual General Meeting, Jun 23, 2022 May 07
Ayr Wellness Inc. Announces Brand Launches in Massachusetts and Ohio May 05
Ayr Wellness Inc. Announces the Launch of Kynd Premium Flower in Florida Apr 22
Ayr Wellness Announces New Launches for Secret Orchard, Levia, Stix Preroll Co., and Origyn Extracts Apr 03
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 18
Ayr Wellness Inc. (CNSX:AYR.A) completed the acquisition of Cultivauna, LLC. Feb 16
Ayr Wellness Inc. to Report Q4, 2021 Results on Mar 17, 2022 Feb 03
Ayr Wellness Adds Joyce Johnson-Miller to Board of Directors Jan 28
Head of Strategy & M&A recently bought €55k worth of stock Dec 17
Ayr Wellness Receives Approval to Begin Operations in 86,000 Sq. Ft. Arizona Cultivation and Production Facility Dec 07
Independent Director recently bought €163k worth of stock Nov 27 Ayr Wellness Inc. (CNSX:AYR.A) entered into a letter of intent to acquire Gentle Ventures, LLC for $55 million.
Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint Nov 23
Forecast to breakeven in 2022 Sep 23 Ayr Wellness Inc. Announces the Launch of Origyn Extracts in Pennsylvania
Head of Strategy & M&A recently bought €70k worth of stock Sep 01
Ayr Wellness Inc. Announces the Launch of Origyn Extracts in Arizona Aug 28
Ayr Wellness Inc. Reiterates Earnings Guidance for 2022 Aug 26
Ayr Wellness Inc. Adds to Florida Retail Footprint, Opens New Dispensary in Boynton Beach Aug 25 Aayr Wellness Inc. Revises Earnings Guidance for the Year 2021
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 3KJB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 3KJB's dividend payments have been increasing.
Dividend Yield vs Market Ayr Wellness Dividend Yield vs Market
How does 3KJB dividend yield compare to the market? Segment Dividend Yield Company (3KJB) n/a Market Bottom 25% (DE) 1.7% Market Top 25% (DE) 4.9% Industry Average (Pharmaceuticals) 1.3% Analyst forecast (3KJB) (up to 3 years) n/a
Notable Dividend: Unable to evaluate 3KJB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 3KJB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 3KJB's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 3KJB has not reported any payouts.
Discover strong dividend paying companies Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}